Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer
about
Genomic profiling in luminal breast cancerClinical advances in molecular biomarkers for cancer diagnosis and therapyStandardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 studyA Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis.Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients.Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancerMammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.Clinical utility of multigene profiling assays in early-stage breast cancer.Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer.Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer.Spotlight on the utility of the Oncotype DX® breast cancer assay.[Molecular pathology for breast cancer: Importance of the gene expression profile].Gene expression profiling in prognosis of distant recurrence in HR-positive and HER2-negative breast cancer patients.
P2860
Q26862681-05D29309-83C1-4786-AB44-49A7307E1CB0Q27027560-7E22609B-EB9B-458C-A530-D56F61DD5AB9Q35462377-1019536B-F38E-4957-85D1-286A30A0D260Q36373710-5CD50BF7-6A66-40A4-90E5-F8300F50087AQ37214217-65D3F29C-2129-4559-9CAA-DEBEDF7562AAQ37383276-53542DCA-3607-4E61-AAFC-481D0E8A31D9Q39190318-C6466F81-C9C1-4BAC-A96D-32369912F65CQ41135590-2804D643-6EF4-48A4-976C-76E0124B8BEFQ41495744-774161EC-6FDA-4A94-A92F-359097D1C5E7Q41545259-0BFE294C-7F6E-4E15-AEDE-2D6535F62323Q47094168-46308BA7-7630-427C-A5DF-D9F5A3A9EF35Q47215343-1789FD4B-0E83-4F66-8D71-E12D156A9645Q48270057-EC746C7D-B88A-4E2F-9BBC-933ED1CD1C10Q52728983-85704778-EDA7-4097-A185-3C21F1D5AB8BQ52868166-222D030F-7517-4649-AAA7-ABAC853E4381Q54963147-172F6648-5BA8-4F2B-9E67-8EDD4EF006A2
P2860
Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Comparison of EndoPredict and ...... ositive invasive breast cancer
@ast
Comparison of EndoPredict and ...... ositive invasive breast cancer
@en
Comparison of EndoPredict and ...... ositive invasive breast cancer
@en-gb
Comparison of EndoPredict and ...... ositive invasive breast cancer
@nl
type
label
Comparison of EndoPredict and ...... ositive invasive breast cancer
@ast
Comparison of EndoPredict and ...... ositive invasive breast cancer
@en
Comparison of EndoPredict and ...... ositive invasive breast cancer
@en-gb
Comparison of EndoPredict and ...... ositive invasive breast cancer
@nl
prefLabel
Comparison of EndoPredict and ...... ositive invasive breast cancer
@ast
Comparison of EndoPredict and ...... ositive invasive breast cancer
@en
Comparison of EndoPredict and ...... ositive invasive breast cancer
@en-gb
Comparison of EndoPredict and ...... ositive invasive breast cancer
@nl
P2093
P2860
P50
P1433
P1476
Comparison of EndoPredict and ...... ositive invasive breast cancer
@en
P2093
Andreas Trojan
Arthur von Hochstetter
Christoph Tausch
Florian Fritzsche
Holger Moch
Peter Schraml
P2860
P304
P356
10.1371/JOURNAL.PONE.0058483
P407
P577
2013-01-01T00:00:00Z